Nano Labs Ltd (NA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Nano Labs Ltd (NA) stock price & volume — 10-year historical chart
Nano Labs Ltd (NA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Nano Labs Ltd (NA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2025Latest | Aug 15, 2025 | $0.03 | $577,558 |
| Q4 2024 | Sep 18, 2024 | $0.06 | $2M |
| Q3 2024 | Aug 21, 2024 | $0.06 | $2M |
| Q2 2024 | Mar 18, 2024 | $0.68 | $2M |
Nano Labs Ltd (NA) competitors in Compute Processors and AI Accelerators — business model, growth, and fundamentals comparison
Nano Labs Ltd (NA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Nano Labs Ltd (NA) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 2.13M | 39.44M | 983.17M | 78.34M | 40.6M | 24.14M |
| Revenue Growth % | - | - | 1754.58% | 2392.77% | -92.03% | -48.18% | -52.49% |
| Cost of Goods Sold | 0 | 1.27M | 43.53M | 753M | 181.78M | 28.99M | 25.62M |
| COGS % of Revenue | - | 59.74% | 110.37% | 76.59% | 232.06% | 71.42% | - |
| Gross Profit | 0▲ 0% | 856.13K▲ 0% | -4.09M▼ 577.7% | 230.16M▲ 5727.8% | -103.45M▼ 144.9% | 11.6M▲ 111.2% | 11.78M▲ 0% |
| Gross Margin % | - | 40.26% | -10.37% | 23.41% | -132.06% | 28.58% | 48.79% |
| Gross Profit Growth % | - | - | -577.71% | 5727.76% | -144.95% | 111.22% | - |
| Operating Expenses | 10.93M | 37.77M | 174.7M | 209.48M | 157.34M | 110.11M | 76.37M |
| OpEx % of Revenue | - | 1776.11% | 442.93% | 21.31% | 200.85% | 271.24% | - |
| Selling, General & Admin | 828.96K | 3.3M | 29.24M | 77.63M | 68.73M | 59.97M | 54.34M |
| SG&A % of Revenue | - | 154.96% | 74.14% | 7.9% | 87.74% | 147.72% | - |
| Research & Development | 10.14M | 34.48M | 145.46M | 131.85M | 88.6M | 50.15M | 24.37M |
| R&D % of Revenue | - | 1621.14% | 368.79% | 13.41% | 113.11% | 123.52% | - |
| Other Operating Expenses | -38.32K | 0 | 0 | 0 | 0 | 0 | -2M |
| Operating Income | -10.97M▲ 0% | -36.92M▼ 236.4% | -178.79M▼ 384.3% | 20.68M▲ 111.6% | -260.79M▼ 1360.8% | -98.51M▲ 62.2% | -77.85M▲ 0% |
| Operating Margin % | - | -1735.85% | -453.3% | 2.1% | -332.91% | -242.66% | -322.51% |
| Operating Income Growth % | - | -236.42% | -384.31% | 111.57% | -1360.79% | 62.22% | - |
| EBITDA | -10.87M | -36.29M | -173.26M | 24.61M | -250.61M | -86.88M | -65.92M |
| EBITDA Margin % | - | -1706.56% | -439.28% | 2.5% | -319.92% | -214.01% | -273.06% |
| EBITDA Growth % | - | -233.97% | -377.38% | 114.21% | -1118.23% | 65.33% | 55.37% |
| D&A (Non-Cash Add-back) | 106.05K | 622.87K | 5.53M | 3.93M | 10.18M | 11.63M | 11.94M |
| EBIT | -10.97M | -37.7M | -174.43M | 204.76M | -253.45M | -112.63M | -66.94M |
| Net Interest Income | 94.57K | 14.17K | 2.99M | 2.01M | -430.96K | -7.8M | -12.04M |
| Interest Income | 94.57K | 17.91K | 3.5M | 2.01M | 489.1K | 504.35K | 0 |
| Interest Expense | 0 | 3.75K | 509.76K | 0 | 920.05K | 6.91M | 12.04M |
| Other Income/Expense | -56.25K | -785.83K | 3.84M | 10.43M | 6.42M | -21.03M | 5.68M |
| Pretax Income | -11.03M▲ 0% | -37.7M▼ 241.8% | -174.94M▼ 364.0% | 31.12M▲ 117.8% | -254.37M▼ 917.4% | -119.54M▲ 53.0% | -72.17M▲ 0% |
| Pretax Margin % | - | -1772.8% | -443.56% | 3.17% | -324.72% | -294.46% | -298.97% |
| Income Tax | 1.59K | 2.29K | 0 | 0 | -17.39K | 0 | 0 |
| Effective Tax Rate % | -0.01% | -0.01% | 0% | 0% | 0.01% | 0% | 0% |
| Net Income | -11.03M▲ 0% | -37.7M▼ 241.8% | -174.94M▼ 364.0% | 31.12M▲ 117.8% | -252.82M▼ 912.4% | -113.19M▲ 55.2% | -63.01M▲ 0% |
| Net Margin % | - | -1772.91% | -443.56% | 3.17% | -322.75% | -278.81% | -261.01% |
| Net Income Growth % | - | -241.8% | -363.99% | 117.79% | -912.44% | 55.23% | 64.46% |
| Net Income (Continuing) | -11.03M | -37.7M | -174.94M | 31.12M | -254.35M | -119.54M | -72.17M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | -1.53M | 2.12M | -2.6M |
| EPS (Diluted) | -0.28▲ 0% | -0.73▼ 160.7% | -3.39▼ 364.4% | 5.84▲ 272.3% | -4.29▼ 173.5% | -1.67▲ 61.1% | -3.81▲ 0% |
| EPS Growth % | - | -160.71% | -364.38% | 272.27% | -173.46% | 61.07% | -130.94% |
| EPS (Basic) | -0.28 | -0.73 | -3.40 | 5.84 | -4.29 | -1.68 | - |
| Diluted Shares Outstanding | 39.62M | 51.95M | 51.95M | 53.66M | 58.89M | 67.67M | 16.55M |
| Basic Shares Outstanding | 39.62M | 51.9M | 51.9M | 53.24M | 58.89M | 67.33M | 16.41M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
Nano Labs Ltd (NA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 20.5M | 59.01M | 893.43M | 288.65M | 125.49M | 366.64M | 1.24B |
| Cash & Short-Term Investments | 10.68M | 35.73M | 265.74M | 91.25M | 50.53M | 275.32M | 1.14B |
| Cash Only | 10.64M | 35.33M | 233.85M | 87.81M | 48.16M | 32.43M | 363.44M |
| Short-Term Investments | 34.27K | 400.18K | 31.89M | 3.43M | 2.36M | 242.89M | 776.7M |
| Accounts Receivable | 0 | 1.17M | 33.08M | 23.73M | 1.74M | 51.4M | 507.69K |
| Days Sales Outstanding | - | 200.07 | 306.11 | 8.81 | 8.1 | 462.17 | 206.38 |
| Inventory | 0 | 7.24M | 213.87M | 102.2M | 12.87M | 29.87M | 35.85M |
| Days Inventory Outstanding | - | 2.08K | 1.79K | 49.54 | 25.85 | 375.99 | 398.02 |
| Other Current Assets | 9.83M | 6.14M | 380.74M | -3.28M | 33.6M | 3.24M | 52.59M |
| Total Non-Current Assets | 1.37M | 2.48M | 16.4M | 78.59M | 224.81M | 249.29M | 239.98M |
| Property, Plant & Equipment | 557.01K | 1.84M | 16.4M | 29.87M | 177.08M | 202.55M | 191.73M |
| Fixed Asset Turnover | - | 1.16x | 2.40x | 32.91x | 0.44x | 0.20x | 0.12x |
| Goodwill | 0 | 0 | 0 | -48.67B | 0 | 0 | 0 |
| Intangible Assets | 265.58K | 99.3K | 0 | 48.72B | 47.73M | 46.75M | 46.25M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 4M |
| Other Non-Current Assets | 550K | 550K | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 21.88M▲ 0% | 61.49M▲ 181.1% | 909.83M▲ 1379.6% | 367.24M▼ 59.6% | 350.3M▼ 4.6% | 615.93M▲ 75.8% | 1.48B▲ 0% |
| Asset Turnover | - | 0.03x | 0.04x | 2.68x | 0.22x | 0.07x | 0.02x |
| Asset Growth % | - | 181.11% | 1379.56% | -59.64% | -4.61% | 75.83% | 697.45% |
| Total Current Liabilities | 32.79M | 109.74M | 932.37M | 183.64M | 242.57M | 209.42M | 682.94M |
| Accounts Payable | 509.53K | 5.62M | 2.84M | 15.29M | 16.88M | 18.1M | 23.2M |
| Days Payables Outstanding | - | 1.61K | 23.79 | 7.41 | 33.88 | 227.88 | 274.2 |
| Short-Term Debt | 6.99M | 5M | 0 | 280K | 23.41M | 23.35M | 510.07M |
| Deferred Revenue (Current) | 0 | 65.4M | 917.39M | 124.47M | 0 | 98.9M | 278.03M |
| Other Current Liabilities | 20.45M | 33.25M | 325.95K | 30.86M | 191.79M | 20.47M | 53.03M |
| Current Ratio | 0.63x | 0.54x | 0.96x | 1.57x | 0.52x | 1.75x | 1.75x |
| Quick Ratio | 0.63x | 0.47x | 0.73x | 1.02x | 0.46x | 1.61x | 1.61x |
| Cash Conversion Cycle | - | 665.93 | 2.08K | 50.94 | 0.07 | 610.28 | 330.2 |
| Total Non-Current Liabilities | 112.97K | 276.65K | 2.12M | 19.19M | 123.99M | 173.6M | 175.7M |
| Long-Term Debt | 0 | 0 | 0 | 16.67M | 120.26M | 170.68M | 173.48M |
| Capital Lease Obligations | 112.97K | 276.65K | 2.12M | 2.51M | 3.73M | 2.92M | 11.3M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -4.72M |
| Total Liabilities | 32.91M | 110.01M | 934.49M | 202.83M | 366.56M | 383.03M | 858.65M |
| Total Debt | 7.23M | 5.74M | 7.35M | 23.67M | 150.88M | 198.87M | 686.79M |
| Net Debt | -3.41M | -29.59M | -226.51M | -64.14M | 102.72M | 166.43M | 323.35M |
| Debt / Equity | - | - | - | 0.14x | - | 0.85x | 0.85x |
| Debt / EBITDA | - | - | - | 0.96x | - | - | -10.42x |
| Net Debt / EBITDA | - | - | - | -2.61x | - | - | -4.91x |
| Interest Coverage | - | -9852.14x | -350.72x | - | -283.45x | -14.25x | -5.56x |
| Total Equity | -11.03M▲ 0% | -48.52M▼ 339.8% | -24.66M▲ 49.2% | 164.41M▲ 766.7% | -16.26M▼ 109.9% | 232.91M▲ 1532.3% | 619.08M▲ 0% |
| Equity Growth % | - | -339.85% | 49.17% | 766.68% | -109.89% | 1532.28% | 6171.51% |
| Book Value per Share | -0.28 | -0.93 | -0.47 | 3.06 | -0.28 | 3.44 | 37.41 |
| Total Shareholders' Equity | -11.03M | -48.52M | -24.66M | 164.41M | -14.73M | 230.79M | 621.69M |
| Common Stock | 51.13K | 51.13K | 66.97K | 72.32K | 87K | 213.74K | 320.37K |
| Retained Earnings | -11.03M | -48.74M | -223.68M | -199.21M | -452.03M | -565.22M | -572.27M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -51.13K | 0 | -2.47M | 8.75M | 2.25M | 15.29M | 13.45M |
| Minority Interest | 0 | 0 | 0 | 0 | -1.53M | 2.12M | -2.6M |
Nano Labs Ltd (NA) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 8.57M | -3.03M | 71.73M | -274.94M | -133.47M | -139.33M | -139.33M |
| Operating CF Margin % | - | -142.38% | 181.87% | -27.96% | -170.39% | -343.21% | - |
| Operating CF Growth % | - | -135.32% | 2469.06% | -483.28% | 51.45% | -4.39% | 141.05% |
| Net Income | -11.03M | -37.7M | -174.94M | 31.12M | -254.35M | -119.54M | -63.01M |
| Depreciation & Amortization | 131.69K | 622.87K | 5.53M | 9.43M | 10.18M | 11.63M | 12.42M |
| Stock-Based Compensation | 0 | 214.88K | 19.34K | 9.35M | 718.41K | 401.52K | 178.35K |
| Deferred Taxes | 0 | -34.05M | 26.75M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 25.6M | 34.05M | -12.09K | 184.07M | 60.88M | 26.55M | -19.21M |
| Working Capital Changes | -6.13M | 33.84M | 214.39M | -508.91M | 49.1M | -58.37M | -43.74M |
| Change in Receivables | 0 | -1.17M | 1.17M | 0 | -1.73M | 1.18M | -18.47K |
| Change in Inventory | 0 | -7.24M | -233.39M | -71.45M | 28.78M | -27.88M | -31.31M |
| Change in Payables | 0 | 390.15K | -2.78M | 10.59M | 898.56K | 1.08M | 0 |
| Cash from Investing | -4.92M | -1.65M | -36.05M | -33.18M | -105.48M | -256.77M | -216.44M |
| Capital Expenditures | -904.03K | -936.78K | -8.69M | -17.53M | -105.48M | -36.37M | -4.03M |
| CapEx % of Revenue | - | 44.05% | 22.04% | 1.78% | 134.66% | 89.58% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -4.01M | -710K | 4.94M | -49.29M | 0 | 16.95K | -212.41M |
| Cash from Financing | 6.99M | 29.36M | 164.9M | 161M | 199.52M | 375.98M | 671.67M |
| Debt Issued (Net) | 0 | 0 | -5M | 16.95M | 126.72M | 50.36M | 0 |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 6.99M | 29.36M | -31.3M | 0 | 0 | 10M | 671.67M |
| Net Change in Cash | 10.64M▲ 0% | 24.69M▲ 132.0% | 198.52M▲ 704.0% | -145.99M▼ 173.5% | -39.28M▲ 73.1% | -15.73M▲ 59.9% | -23.92M▲ 0% |
| Free Cash Flow | 7.67M▲ 0% | -3.96M▼ 151.7% | 63.04M▲ 1690.0% | -341.76M▼ 642.1% | -238.96M▲ 30.1% | -175.7M▲ 26.5% | -117.39M▲ 0% |
| FCF Margin % | - | -186.43% | 159.83% | -34.76% | -305.04% | -432.79% | -486.28% |
| FCF Growth % | - | -151.71% | 1690.05% | -642.14% | 30.08% | 26.47% | 48.51% |
| FCF per Share | 0.19 | -0.08 | 1.21 | -6.37 | -4.06 | -2.60 | -2.60 |
| FCF Conversion (FCF/Net Income) | -0.78x | 0.08x | -0.41x | -8.84x | 0.53x | 1.23x | 1.86x |
| Interest Paid | 0 | 0 | 0 | 180.62K | 0 | 9.28M | 13.51M |
| Taxes Paid | 0 | 0 | 276.19K | 89.17K | 0 | 0 | 0 |
Nano Labs Ltd (NA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | 44.53% | -341.3% | -104.49% | -10.18% |
| Return on Invested Capital (ROIC) | - | - | - | -209.49% | -30.42% | -30.42% |
| Gross Margin | 40.26% | -10.37% | 23.41% | -132.06% | 28.58% | 48.79% |
| Net Margin | -1772.91% | -443.56% | 3.17% | -322.75% | -278.81% | -261.01% |
| Debt / Equity | - | - | 0.14x | - | 0.85x | 0.85x |
| Interest Coverage | -9852.14x | -350.72x | - | -283.45x | -14.25x | -5.56x |
| FCF Conversion | 0.08x | -0.41x | -8.84x | 0.53x | 1.23x | 1.86x |
| Revenue Growth | - | 1754.58% | 2392.77% | -92.03% | -48.18% | -52.49% |
Nano Labs Ltd (NA) stock FAQ — growth, dividends, profitability & financials explained
Nano Labs Ltd (NA) reported $24.1M in revenue for fiscal year 2024.
Nano Labs Ltd (NA) saw revenue decline by 48.2% over the past year.
Nano Labs Ltd (NA) reported a net loss of $63.0M for fiscal year 2024.
Nano Labs Ltd (NA) has a return on equity (ROE) of -104.5%. Negative ROE indicates the company is unprofitable.
Nano Labs Ltd (NA) had negative free cash flow of $117.4M in fiscal year 2024, likely due to heavy capital investments.
Nano Labs Ltd (NA) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates